A dedicated cancer research hub
in Cyprus

Virtual Tour Video

Cyprus Cancer Institute

“An interdisciplinary network of leading academic, clinical  and diagnostic partners came together to establish the Cyprus Cancer Research Institute (CCRI), a non-for-profit, dedicated centre of excellence in cancer research.”

Promoting high caliber cancer research in Cyprus and
educating the next generation of cancer research scientists

State of the Art Research Infrastructure

• Housed in a purpose-built modern building to create an inspiring and vibrant scientific environment.
• Access to advanced research tools and resources required for cancer research.
• Act as an inspirational hub to promote cancer research and showcase its importance and impact to the next generation.

Optimised Resource Management​

• A platform of core facilities and services.
• Access to the requisite equipment including the latest technologies and specialist expertise.
• Decentralized procedures and other research support mechanisms to guarantee autonomous operation of facilities.
• Supported by an efficient and effective administrative support system that will reduce administrative burden on scientists.
• A structured quality control system that will include clear operating procedures and regulations and quality indicators

Excellence in Research​

• Strong foundation for high quality research.
• Rigorous selection of outstanding scientists.
• Creation of a leading research support system.

Investment in People​

• Invest in people through an ambitious scientific development program.
• Advanced Training Courses, locally and abroad.
•Scientific contributions.
• Funding applications.
• Scientific exchange programs.
• Scientific mentors.

Latest News & Announcements

Get the latest updates, news, and announcements all in one place. Stay informed with the newest features and events

Celebrating a Landmark Achievement in WWOX Research and Precision Medicine

We are proud to congratulate Prof. Rami Aqeilan on a truly outstanding scientific and clinical achievement. An infant with WOREE syndrome (WWOX-related epileptic encephalopathy) has become the first patient in the world to receive an experimental gene replacement therapy designed to restore WWOX function in the brain, marking a major milestone in precision medicine for rare neurological disorders. This achievement is the culmination of more than a decade of research

Read More

PRECISION ImmunoRad: Ξεπερνώντας την αντοχή των όγκων στην ανοσοθεραπεία.

Το Ευρωπαϊκό Συμβούλιο Έρευνας  χρηματοδοτεί διεθνές έργο με τη συμμετοχή του Ινστιτούτου Καρκίνου Κύπρου. Το Ευρωπαϊκό Συμβούλιο Έρευνας (ERC) ανακοίνωσε τη χρηματοδότηση του έργου PRECISION ImmunoRad στο πρόγραμμα Συνέργεια (ERC synergy) με τη συμμετοχή του Ινστιτούτου ‘Ερευνας Καρκίνου Κύπρου (CCRI) υπό τον καθηγητή Κωνσταντίνο Κουμένη. Το CCRI που ιδρύθηκε το 2019 με τη γενναιόδωρη δωρεά του Ιδρύματος “George and Kaity David”, με θεσμική συμμετοχή του Πανεπιστημίου Κύπρου, του Ογκολογικού Κέντρου Τράπεζας

Read More